Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
--------------------------------------------------------------------
Source: Zero Hedge
Published: 2026-06-02 21:45 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Business, Health, Financial Markets, Law & Courts, Drugs, Crime & Justice
--------------------------------------------------------------------
Snippet:
French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to regulatory headwinds and raise the risk profile for approval.
--------------------------------------------------------------------